In our study, considering the restrictive expression of FAP, HT1080 cells overexpressing FAP (hFAP-HT1080) was applied to verify that the hFAP-CAR T cells could lyse hFAP-positive tumor cells specifically in vitro and in vivo. The gene discussed is FAP; the disease is neoplasm.